Back to search

France· FR:68820460

NIFLURIL ENFANTS 400 mg, suppositoire sécable

A morniflumate product containing morniflumate, registered in France by UPSA, on the national reimbursement list.

Reimbursed in France (Assurance maladie)ATC M01AX22

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNIFLURIL ENFANTS 400 mg, suppositoire…ATCM01AX22REGISTER NO.FR:68820460PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MORNIFLUMATE
Manufacturer
UPSA
Country
France (FR)
ATC code
M01AX22
ATC class
Morniflumate
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400931886365
    2 film(s) thermosoudé(s) PVC polyéthylène basse densité (PEBD) de 4 suppositoire(s)
    EUR 1.74

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M01AX22

Morniflumate, as other registers publish it.

All morniflumate products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Italy · Flomax, Flomax Adulti

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fa66408a-831b-430b-95bd-3d8281171ec6
GET /v1/drugs/fa66408a-831b-430b-95bd-3d8281171ec6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68820460",
  "date_amm": "1996-10-17",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "MORNIFLUMATE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "suppositoire sécable",
  "voies_administration": "rectale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about morniflumate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.